Sectors
GILD
Gilead Sciences, Inc.
135.77
5 x 135.00
1 x 135.52
bid
ask
+
2.71
2.04%
2 @ 04:00 PM
135.07 -0.70 (0.51%)
| Ytd | 10.62% | |
| 1y | 12.70% |
132.01
day range
136.85
108.46
52 week range
157.29
| Open | 132.61 | Prev Close | 133.06 | Low | 132.01 | High | 136.85 | Mkt Cap | 168.57B |
| Vol | 5.41M | Avg Vol | 7.75M | EPS | -0.39 | P/E | -348.13 | Forward P/E | 13.48 |
| Beta | 0.34 | Short Ratio | 3.06 | Inst. Own | 92.80% | Dividend | 3.28 | Div Yield | 2.46 |
| Ex Div Date | 09-15 | Earning | 08-06 | 50-d Avg | 129.66 | 200-d Avg | 132.12 | 1yr Est | 157.41 |
| Income Statement | |||
| Total Revenue | 7.80B | ||
| Revenues (USD) | 7.80B | ||
| Cost of Revenue | 1.58B | ||
| Gross Profit | 6.22B | ||
| Operating Expenses | 16.62B | ||
| Research and Development Expense | 1.76B | ||
| Selling, General and Administrative Expense | 1.92B | ||
| Operating Income | -10.39B | ||
| Interest Expense | 247.00M | ||
| Income Tax Expense | 242.00M | ||
| Net Income | -10.50B | ||
| Net Income Common Stock | -10.50B | ||
| Net Income Common Stock (USD) | -10.50B | ||
| Consolidated Income | -10.50B | ||
| Earnings per Basic Share | -8.45 | ||
| Earnings per Basic Share (USD) | -8.45 | ||
| Earnings per Diluted Share | -8.45 | ||
| Dividends per Basic Common Share | 0.82 | ||
| Earning Before Interest & Taxes (EBIT) | -10.01B | ||
| Earning Before Interest & Taxes (USD) | -10.01B | ||
| Weighted Average Shares | 1.24B | ||
| Weighted Average Shares Diluted | 1.24B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.18B | ||
| Cash and Equivalents (USD) | 3.18B | ||
| Trade and Non-Trade Receivables | 5.06B | ||
| Current Assets | 13.95B | ||
| Property, Plant & Equipment Net | 5.83B | ||
| Total Assets | 49.36B | ||
| Debt Current | 2.41B | ||
| Total Debt | 26.25B | ||
| Current Liabilities | 11.02B | ||
| Debt Non-Current | 23.83B | ||
| Total Liabilities | 37.62B | ||
| Accumulated Retained Earnings (Deficit) | 2.20B | ||
| Accumulated Other Comprehensive Income | 95.00M | ||
| Shareholders Equity | 11.83B | ||
| Shareholders Equity (USD) | 11.83B | ||
| Assets Non-Current | 35.42B | ||
| Total Debt (USD) | 26.25B | ||
| Goodwill and Intangible Assets | 22.35B | ||
| Inventory | 1.95B | ||
| Liabilities Non-Current | 26.60B | ||
| Trade and Non-Trade Payables | 674.00M | ||
| Tax Assets | 2.49B | ||
| Tax Liabilities | 1.28B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 698.00M | ||
| Net Cash Flow from Financing | 2.34B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.45B | ||
| Capital Expenditure | -140.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -11.21B | ||
| Issuance (Purchase) of Equity Shares | -346.00M | ||
| Issuance (Repayment) of Debt Securities | 4.07B | ||
| Payment of Dividends & Other Cash Distributions | -1.03B | ||
| Net Cash Flow from Investing | -10.35B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 983.00M | ||
| Net Cash Flow from Operations | 3.57B | ||
| Effect of Exchange Rate Changes on Cash | -19.00M | ||
| Share Based Compensation | 231.00M | ||